![Cristina Csimma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cristina Csimma
Président chez
Caraway Therapeutics, Inc.
Profil
Cristina Csimma is the founder of Cydan II, Inc. Current jobs include Chairman at Caraway Therapeutics, Inc. since 2019, Executive Chairman at Sardona Therapeutics, Inc., Independent Director at Asgard Therapeutics AB, and Member-Managers Board at New York Blood Center, Inc. Former jobs include President & Chief Executive Officer at Cydan LLC, Chairman at Forendo Pharma Oy from 2020 to 2021, Executive Chairman at Exonics Therapeutics, Inc. from 2016 to 2017, Independent Director at Catalent JNP, Inc. from 2010 to 2018, Associate Director-Clinical Research at Genetics Institute LLC from 1988 to 2000, Independent Director at Idera Pharmaceuticals, Inc., Independent Director at Seneca Biopharma, Inc., Director-Clinical Research & Development at Wyeth-Ayerst Research in 2001, Senior Director-Translational Research at Pfizer Pharmaceuticals, Inc. in 2006, Director at T1D Exchange from 2018 to 2020, Independent Non-Executive Director at Syncona Ltd., Independent Director at Vtesse, Inc. from 2014 to 2017, Independent Director at Palisade Bio, Inc. from 2017 to 2024, Independent Director at Aceragen, Inc. from 2019 to 2023, Vice President-Drug Development at Virdante Pharmaceuticals, Inc. from 2009 to 2011, Principal at Dana-Farber Cancer Institute, Inc. from 1983 to 1988, and Principal at Clarus Ventures LLC.
Education includes undergraduate and doctorate degrees from Massachusetts College of Pharmacy & Health Science and a graduate degree from Northeastern University.
Postes actifs de Cristina Csimma
| Sociétés | Poste | Début |
|---|---|---|
Caraway Therapeutics, Inc.
 Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases | Président | 01/04/2019 |
Sardona Therapeutics, Inc.
 Sardona Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer therapy services | Président | - |
New York Blood Center, Inc.
 New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Corporate Officer/Principal | - |
Asgard Therapeutics AB
 Asgard Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Engages in biotechnological research and development activities | Directeur/Membre du Conseil | - |
Anciens postes connus de Cristina Csimma
| Sociétés | Poste | Fin |
|---|---|---|
| PALISADE BIO, INC. | Directeur/Membre du Conseil | 09/02/2024 |
| ACERAGEN, INC. | Directeur/Membre du Conseil | 15/08/2023 |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Président | 01/12/2021 |
T1D Exchange
 T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Directeur/Membre du Conseil | 01/01/2020 |
| JUNIPER PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | - |
Formation de Cristina Csimma
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Health Services |
Virdante Pharmaceuticals, Inc.
 Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Develops and commercializes drugs | Distribution Services |
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
Wyeth-Ayerst Research | |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Develops and commercializes drugs | Health Technology |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Operates as an orphan drug accelerator that identifies and de-risks programs | Distribution Services |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology Operates as type 1 diabetes data platform | Health Technology |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases | Health Technology |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
Caraway Therapeutics, Inc.
Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases | Health Technology |
Asgard Therapeutics AB
Asgard Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Engages in biotechnological research and development activities | Commercial Services |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Sardona Therapeutics, Inc.
Sardona Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer therapy services | Health Services |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
